YANKCOM Partnership »

Recursion Pharmaceuticals shares owned by YANKCOM Partnership

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by YANKCOM Partnership from 13F filings

Historical chart of YANKCOM Partnership investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by YANKCOM Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by YANKCOM Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2k 300 4.09

More positions owned by YANKCOM Partnership

Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Vanguard Index Funds S&P 500 ETF S&p 500 Etf Shs (VOO)
Schwab Strategic Tr US Large-Cap Value ETF Us Lcap Va Etf (SCHV)
iShares Tr S&P Midcap 400 ETF Core S&p Mcp Etf (IJH)
iShares Tr Russell Top 200 Growth ETF Rus Tp200 Gr Etf (IWY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Cap Stock Cl A Cap Stk Cl A (GOOGL)
Vanguard FTSE Emerging Markets ETF Ftse Emr Mkt Etf (VWO)
SPDR Portfolio Developed World Ex-US ETF Portfolio Devlpd (SPDW)
Citigroup Com New (C)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)

View all positions for YANKCOM Partnership

Top funds holding Recursion Pharmaceuticals

Vanguard Group
ARK Investment Management
BlackRock
Baillie Gifford & Co
State Street Corporation
Softbank Group Corp
Kinnevik AB
Mubadala Investment Co PJSC
MIC Capital Management UK
Geode Capital Management
Susquehanna International
Novo A/S
Nvidia Corp
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings

View all funds holding Recursion Pharmaceuticals